Publications Database

Accordino R. E. et al. (2016)

Psychopharmacological interventions in autism spectrum disorder.

Expert Opinion on Pharmacotherapy

May, 17(7), pp. 937-952.

Read Abstract (New Window)

Alderton H. (1970)

Imipramine in childhood nocturnal enuresis: relationship of time of administration to effect.

Canadian Psychiatric Association Journal

102 pp. 197-203

Read Full (New Window)

Baribeau D. A. , Anagnostou E. (2014)

Social communication is an emerging target for pharmacotherapy in autism spectrum disorder: A review of the literature on potential agents.

Journal of Canadian Academic Child Adolescent Psychiatry

23(1), pp. 20-30.

Read Abstract (New Window) Read Full (New Window)

Brett , Cohen I. (2002)

Use of a GABA-transaminase agonist for treatment of infantile autism.

Medical Hypotheses

59(1), pp. 115-116

Read Abstract (New Window)

Erickson C. A. et al. (2014)

STX209 (Arbaclofen) for autism spectrum disorders: An 8-week open-label study.

Journal of Autism and Developmental Disorders

44(4), pp. 958-964.

Read Abstract (New Window)

Frye R. E. (2014)

Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder.

Drug, Healthcare and Patient Safety

6 pp. 69-76.

Read Abstract (New Window) Read Full (New Window)

Gürkana C. K. , Hagerman R. J. (2012)

Targeted treatments in autism and fragile X syndrome.

Research in Autism Spectrum Disorders

6(4), pp. 1311-1320.

Read Abstract (New Window)

Hampson D. R. , Adusei D. C. , Pacey L. K. K. (2011)

The neurochemical basis for the treatment of autism spectrum disorders and Fragile X syndrome.

Biochemical Pharmacology

81(9), pp. 1078-1086

Read Abstract (New Window)

Howes O. D. et al.

Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.

Journal of Psychopharmacology

Read Abstract (New Window)

Jorgensen O. (1979)

Psychopharmacological treatment of psychotic children. A survey.

Acta Psychiatrica Scandinavica

59(2), pp. 229-238

Read Abstract (New Window)

Peñagarikan O. (2014)

New therapeutic options for autism spectrum disorder: Experimental evidences.

Experimental Neurobiology

December, 24(4), pp. 301-311.

Read Abstract (New Window) Read Full (New Window)

Veenstra-VanderWeele J. et al.

Arbaclofen in children and adolescents with autism spectrum disorder: A randomized, controlled, phase 2 trial.

Neuropsychopharmacology

Read Abstract (New Window)